AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vasoglim M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Vasolife Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Vasoglim M 1mg/500mg Tablet ER

Diabex Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is vital, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Vasoglim M 1mg/500mg Tablet ER

No text provided to rephrase.

Uses of Vasoglim M 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Vasoglim M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vasoglim M 1mg/500mg Extended-Release tablet whole; do not chew, crush, or divide it. Consume this medication with food.

Common Side effects of Vasoglim M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Vasoglim M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vasoglim M 1mg/500mg Extended-Release Tablets. Ingest the tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

How Vasoglim M 1mg/500mg Tablet ER works:

Vasoglim M ER tablets (1mg/500mg) contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Vasoglim M 1mg/500mg extended-release tablets is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vasoglim M 1mg/500mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Vasoglim M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vasoglim M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. The medication is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Vasoglim M 1mg/500mg Extended-Release tablets cautiously. Dosage modifications may be necessary for Vasoglim M 1mg/500mg Extended-Release tablets in such cases. Physician consultation is advised. Initiation of Vasoglim M 1mg/500mg Extended-Release tablets typically begins with a low dose for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Vasoglim M 1mg/500mg Tablet ER :

Should you forget to take a Vasoglim M 1mg/500mg Extended-Release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vasoglim M 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vasoglim M 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Vasoglim M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vasoglim M 1mg/500mg Tablet ER and seek immediate medical attention.
Vasoglim M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Vasoglim M 1mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Vasoglim M 1mg/500mg Tablet ER can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake at least annually is recommended by some researchers.
Vasoglim M 1mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Vasoglim M 1mg/500mg ER tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Vasoglim M 1mg/500mg Tabl...
35
MRP 40
12% off